About Aurobindo Pharma Limited (AUROPHARMA)
Aurobindo Pharma Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector.
AUROPHARMA trades on the Indian stock exchanges (NSE/BSE) and is classified as a large-cap stock .
Key Statistics
- Current Price
- ₹1,681.40
- Market Cap
- ₹967.44B
- 52-Week High
- ₹1,740.00
- 52-Week Low
- ₹1,106.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
₹1,000 Invested in Aurobindo Pharma Limited (AUROPHARMA)
How much would ₹1,000 invested in AUROPHARMA be worth today?
What would ₹1,000 invested in AUROPHARMA 1 year ago be worth today?
A ₹1,000 investment in Aurobindo Pharma Limited (AUROPHARMA) in 2025 would be worth ₹1,530 as of November 2026, representing a +53.0% total return.
What would ₹1,000 invested in AUROPHARMA 3 years ago be worth today?
A ₹1,000 investment in Aurobindo Pharma Limited (AUROPHARMA) in 2023 would be worth ₹1,882 as of November 2026, representing a +88.2% total return.
What would ₹1,000 invested in AUROPHARMA 5 years ago be worth today?
A ₹1,000 investment in Aurobindo Pharma Limited (AUROPHARMA) in 2021 would be worth ₹2,395 as of November 2026, representing a +139.5% total return.
What would ₹1,000 invested in AUROPHARMA 10 years ago be worth today?
A ₹1,000 investment in Aurobindo Pharma Limited (AUROPHARMA) in 2016 would be worth ₹2,363 as of November 2026, representing a +136.3% total return.
What would ₹1,000 invested in AUROPHARMA at IPO be worth today?
A ₹1,000 investment in Aurobindo Pharma Limited (AUROPHARMA) at IPO would be worth ₹395,898 as of November 2026, representing a +39489.8% total return.
Monthly Returns Heatmap
Over the past 30+ years (369 months), Aurobindo Pharma Limited (AUROPHARMA) has averaged a monthly return of +2.98% with a median return of +1.38%. The stock had 206 positive months (56%) and 162 negative months (44%). The best month in AUROPHARMA's history was December 1999 with a +108.4% return, while the worst was October 2008 at -54.7%. Historically, December tends to be the strongest month (averaging +11.2%), and October the weakest (-2.8%).
AUROPHARMA's longest winning streak was 8 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 1999 with a cumulative return of +257.3%, and the worst was 2011 at -95.3%.
Annual Returns
Over 30 years of trading history, Aurobindo Pharma Limited (AUROPHARMA) has delivered an average annual return of +66.40% with a median return of +24.58%. The compound annual growth rate (CAGR) is +23.83%. The stock posted gains in 18 years (60%) and losses in 12 years (40%).
AUROPHARMA's best year was 1999 with a +574.62% gain, while the worst was 2008 at -68.64%. The longest streak of consecutive positive years was 4, and the longest losing streak was 3 years. AUROPHARMA achieved double-digit gains (10%+) in 16 years. It suffered double-digit losses in 11 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +42.13% | ₹1,183.00 | ₹1,681.40 |
| 2025 | -11.02% | ₹1,329.51 | ₹1,183.00 |
| 2024 | +23.29% | ₹1,078.39 | ₹1,329.51 |
| 2023 | +149.62% | ₹432.02 | ₹1,078.39 |
| 2022 | -39.67% | ₹716.06 | ₹432.02 |
| 2021 | -19.81% | ₹892.96 | ₹716.06 |
| 2020 | +102.95% | ₹439.99 | ₹892.96 |
| 2019 | -37.39% | ₹702.73 | ₹439.99 |
| 2018 | +6.89% | ₹657.42 | ₹702.73 |
| 2017 | +3.22% | ₹636.91 | ₹657.42 |
| 2016 | -23.31% | ₹830.50 | ₹636.91 |
| 2015 | +54.86% | ₹536.28 | ₹830.50 |
| 2014 | +190.43% | ₹184.65 | ₹536.28 |
| 2013 | +110.05% | ₹87.91 | ₹184.65 |
| 2012 | +124.65% | ₹39.13 | ₹87.91 |
| 2011 | -67.41% | ₹120.07 | ₹39.13 |
| 2010 | +46.54% | ₹81.94 | ₹120.07 |
| 2009 | +454.08% | ₹14.79 | ₹81.94 |
| 2008 | -68.64% | ₹47.17 | ₹14.79 |
| 2007 | -22.78% | ₹61.08 | ₹47.17 |
| 2006 | +72.31% | ₹35.45 | ₹61.08 |
| 2005 | +25.87% | ₹28.16 | ₹35.45 |
| 2004 | -23.53% | ₹36.83 | ₹28.16 |
| 2003 | +313.68% | ₹8.90 | ₹36.83 |
| 2002 | -7.29% | ₹9.60 | ₹8.90 |
| 2001 | -53.32% | ₹20.57 | ₹9.60 |
| 2000 | -59.59% | ₹50.90 | ₹20.57 |
| 1999 | +574.62% | ₹7.55 | ₹50.90 |
| 1998 | +68.51% | ₹4.48 | ₹7.55 |
| 1997 | +62.09% | ₹2.76 | ₹4.48 |
Frequently Asked Questions: AUROPHARMA
What sector is AUROPHARMA in? ▼
AUROPHARMA operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has AUROPHARMA performed historically? ▼
Over 30 years of trading history, AUROPHARMA has posted gains in 18 years (60% of the time). The best year was 1999 with a +574.6% return. Past performance does not guarantee future results.
How can I invest in AUROPHARMA? ▼
You can invest in AUROPHARMA through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold AUROPHARMA.
Last updated: 11/1/2026